TechNavio today launched its report Contract Research Organization Market in the US 2011-2015 based on an in-depth study exclusively focusing on the US. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The major trend witnessed by the Contract Research Organization (CRO) market in the US is the emergence of CROs in developing countries such as India and China. Pharmaceutical and biopharmaceutical vendors in the US are outsourcing their R&D activities to these CROs. The cost-containment pressures on the pharmaceutical and biopharmaceutical vendors in the US coupled with demand for high-quality services and huge infrastructure investment have resulted in increasing outsourcing of clinical trials to overseas locations. Furthermore, leading CROs are moving their headquarters to Singapore and China to strengthen their footprint in Asia.”
According to the report, the key driver in the CRO market in the US is the increasing outsourcing of R&D activities by pharmaceutical and biopharmaceutical vendors. Pharmaceutical and biopharmaceutical vendors are making huge efforts to reduce RandD expenditure and increase profitability by outsourcing clinical trial activities to CROs.
Further, the report also discusses that one of the major challenges in the CRO market in the US is the shortage of clinical research personnel.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit http://goo.gl/ylw47
Follow us on Twitter @ Technavio